RT Journal Article
SR Electronic
T1 Homophily in risk and behavior complicate understanding the COVID-19 epidemic curve
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.16.21253708
DO 10.1101/2021.03.16.21253708
A1 Fefferman, Nina H.
A1 Silk, Matthew J.
A1 Pasquale, Dana K.
A1 Moody, James
YR 2021
UL http://medrxiv.org/content/early/2021/03/20/2021.03.16.21253708.abstract
AB New COVID-19 diagnoses have dropped faster than expected in the United States. Interpretations of the decrease have focused on changing factors (e.g. mask-wearing, vaccines, etc.), but predictive models largely ignore heterogeneity in behaviorally-driven exposure risks among distinct groups. We present a simplified compartmental model with differential mixing in two behaviorally distinct groups. We show how homophily in behavior, risk, and exposure can lead to early peaks and rapid declines that critically do not signal the end of the outbreak. Instead, higher exposure risk groups may more rapidly exhaust available susceptibles while the lower risk group are still in a (slower) growth phase of their outbreak curve. This simplified model demonstrates that complex incidence curves, such as those currently seen in the US, can be generated without changes to fundamental drivers of disease dynamics. Correct interpretation of incidence curves will be critical for policy decisions to effectively manage the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe following funding supported this work, but did not influence study design or interpretation in any way: National Science Foundation award DEB 2028710 (NHF) National Science Foundation award 2029790 (JM, DKP) James S. McDonnell Foundation award 220020397 (JM) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere is no primary data associated with this study.